Sequencing

Caris Life Sciences Raises $400M in Senior Secured Debt Financing

Prenetics' ACT Genomics Profiling Test for Solid Tumors Receives FDA Clearance

Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses

AstraZeneca to Evaluate C2i Genomics' Cancer Detection, Monitoring Platform

Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response

FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek

Esophageal Cancer Molecular Study Highlights Tumor Subtypes, Treatment Response Markers

Study Shows Potential of Drug Sensitivity Profiling With Sequencing for Pediatric Cancers

Multiomic Study Points to New Colorectal Cancer Risk Contributors

Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M

Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK

T-Cell Subpopulations in Blood May Help Predict Immune Checkpoint Immunotherapy Side Effects

FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy

Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement

Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer

Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment